From this study, HDAC4 was found to be, together with TNM stage, a significant predictor of overall survival and a marginally significant parameter of progression free survival in patients with ESCC, suggesting its potential use as a biomarker for ESCC patients’ prognosis.
← all excerpts
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment.
1
—
—